Concepts (113)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Cryoelectron Microscopy | 4 | 2020 | 2372 | 0.63 | Why? |
| Single-Domain Antibodies | 2 | 2020 | 744 | 0.59 | Why? |
| Spike Glycoprotein, Coronavirus | 13 | 2021 | 37182 | 0.42 | Why? |
| Porcine epidemic diarrhea virus | 1 | 2019 | 1017 | 0.41 | Why? |
| Protein Domains | 6 | 2021 | 6563 | 0.30 | Why? |
| Antibodies, Monoclonal | 7 | 2021 | 8041 | 0.30 | Why? |
| Models, Molecular | 6 | 2021 | 7616 | 0.28 | Why? |
| Antibodies, Neutralizing | 9 | 2021 | 25288 | 0.27 | Why? |
| Respiratory Syncytial Virus Infections | 3 | 2018 | 1234 | 0.26 | Why? |
| Viral Fusion Proteins | 2 | 2018 | 399 | 0.25 | Why? |
| Cross Reactions | 5 | 2021 | 4374 | 0.25 | Why? |
| Protein Conformation | 4 | 2020 | 4386 | 0.23 | Why? |
| Camelids, New World | 2 | 2020 | 276 | 0.22 | Why? |
| Somatic Hypermutation, Immunoglobulin | 2 | 2020 | 283 | 0.22 | Why? |
| Receptors, Virus | 5 | 2020 | 5659 | 0.21 | Why? |
| Immunoglobulin Fc Fragments | 2 | 2021 | 691 | 0.20 | Why? |
| Respiratory Syncytial Virus Vaccines | 2 | 2018 | 104 | 0.20 | Why? |
| Protein Stability | 2 | 2020 | 756 | 0.19 | Why? |
| Crystallization | 1 | 2019 | 331 | 0.18 | Why? |
| Palivizumab | 1 | 2017 | 32 | 0.17 | Why? |
| Protein Binding | 5 | 2021 | 11430 | 0.17 | Why? |
| Alphacoronavirus | 1 | 2019 | 392 | 0.14 | Why? |
| Proteolysis | 1 | 2018 | 751 | 0.14 | Why? |
| Protein Structure, Secondary | 1 | 2018 | 1077 | 0.14 | Why? |
| Epitopes | 3 | 2021 | 4113 | 0.14 | Why? |
| Protein Multimerization | 1 | 2020 | 1336 | 0.13 | Why? |
| Vaccines, DNA | 1 | 2020 | 871 | 0.13 | Why? |
| Amino Acid Substitution | 1 | 2020 | 1706 | 0.13 | Why? |
| Respiratory Syncytial Viruses | 1 | 2017 | 612 | 0.12 | Why? |
| Betacoronavirus | 7 | 2021 | 204454 | 0.12 | Why? |
| Mice, Inbred BALB C | 5 | 2021 | 5814 | 0.12 | Why? |
| Antibodies, Viral | 8 | 2021 | 51949 | 0.12 | Why? |
| Polysaccharides | 1 | 2020 | 854 | 0.12 | Why? |
| Viral Vaccines | 4 | 2020 | 7560 | 0.11 | Why? |
| B-Lymphocytes | 3 | 2021 | 4418 | 0.11 | Why? |
| Image Processing, Computer-Assisted | 1 | 2020 | 1383 | 0.11 | Why? |
| SARS Virus | 5 | 2021 | 13021 | 0.11 | Why? |
| Proteins | 1 | 2019 | 921 | 0.11 | Why? |
| Binding Sites | 5 | 2021 | 6201 | 0.11 | Why? |
| Respiratory Syncytial Virus, Human | 1 | 2017 | 846 | 0.10 | Why? |
| High-Throughput Screening Assays | 1 | 2019 | 1783 | 0.10 | Why? |
| Proline | 2 | 2020 | 345 | 0.08 | Why? |
| Animals | 10 | 2021 | 78931 | 0.08 | Why? |
| Peptidyl-Dipeptidase A | 4 | 2020 | 9659 | 0.08 | Why? |
| Mice | 6 | 2021 | 21357 | 0.07 | Why? |
| Epitope Mapping | 2 | 2021 | 1240 | 0.07 | Why? |
| Antibody Affinity | 2 | 2021 | 1078 | 0.07 | Why? |
| Glycosylation | 2 | 2020 | 1255 | 0.07 | Why? |
| Immunoglobulin G | 4 | 2021 | 21571 | 0.07 | Why? |
| Antigens, Viral | 1 | 2020 | 6298 | 0.06 | Why? |
| Directed Molecular Evolution | 1 | 2021 | 81 | 0.06 | Why? |
| Immunoglobulin Fragments | 1 | 2021 | 78 | 0.06 | Why? |
| Crystallography, X-Ray | 2 | 2019 | 2689 | 0.05 | Why? |
| Cell Surface Display Techniques | 1 | 2021 | 170 | 0.05 | Why? |
| Oligosaccharides | 1 | 2020 | 69 | 0.05 | Why? |
| Binding Sites, Antibody | 1 | 2021 | 466 | 0.05 | Why? |
| Antigen-Antibody Reactions | 1 | 2021 | 616 | 0.05 | Why? |
| Guinea Pigs | 1 | 2020 | 420 | 0.05 | Why? |
| Phagocytosis | 1 | 2021 | 409 | 0.05 | Why? |
| B-Lymphocyte Subsets | 1 | 2020 | 372 | 0.05 | Why? |
| Immunologic Memory | 2 | 2021 | 3362 | 0.04 | Why? |
| Protein Subunits | 1 | 2021 | 755 | 0.04 | Why? |
| Glycopeptides | 1 | 2020 | 199 | 0.04 | Why? |
| Trypsin | 1 | 2018 | 209 | 0.04 | Why? |
| Protein Engineering | 1 | 2021 | 536 | 0.04 | Why? |
| Toll-Like Receptor 4 | 1 | 2020 | 390 | 0.04 | Why? |
| Models, Animal | 1 | 2020 | 788 | 0.04 | Why? |
| Clinical Trials, Phase III as Topic | 1 | 2020 | 782 | 0.04 | Why? |
| Protein Structure, Tertiary | 1 | 2020 | 1565 | 0.04 | Why? |
| Mutation | 3 | 2021 | 12376 | 0.04 | Why? |
| Mass Spectrometry | 1 | 2020 | 1165 | 0.03 | Why? |
| Th1 Cells | 1 | 2020 | 1228 | 0.03 | Why? |
| Immunity, Humoral | 2 | 2020 | 4849 | 0.03 | Why? |
| Nose | 1 | 2020 | 1093 | 0.03 | Why? |
| Vero Cells | 2 | 2021 | 14117 | 0.03 | Why? |
| Coronavirus Infections | 7 | 2020 | 253789 | 0.03 | Why? |
| Coronaviridae | 1 | 2017 | 923 | 0.03 | Why? |
| Macaca mulatta | 1 | 2021 | 3716 | 0.03 | Why? |
| Peptide Hydrolases | 1 | 2018 | 1269 | 0.03 | Why? |
| Structure-Activity Relationship | 1 | 2017 | 2219 | 0.03 | Why? |
| Viral Tropism | 1 | 2018 | 1329 | 0.03 | Why? |
| Recombinant Proteins | 1 | 2020 | 3786 | 0.02 | Why? |
| Humans | 13 | 2021 | 930598 | 0.02 | Why? |
| Middle East Respiratory Syndrome Coronavirus | 2 | 2020 | 8843 | 0.02 | Why? |
| Severe Acute Respiratory Syndrome | 2 | 2021 | 12361 | 0.02 | Why? |
| Neutralization Tests | 1 | 2020 | 6698 | 0.02 | Why? |
| RNA, Messenger | 1 | 2020 | 5131 | 0.02 | Why? |
| Cell Line | 1 | 2021 | 12040 | 0.02 | Why? |
| Longitudinal Studies | 1 | 2021 | 9893 | 0.02 | Why? |
| HEK293 Cells | 1 | 2018 | 8394 | 0.02 | Why? |
| Female | 6 | 2021 | 380317 | 0.02 | Why? |
| Immunization, Passive | 1 | 2021 | 10067 | 0.02 | Why? |
| Infant | 2 | 2018 | 30274 | 0.02 | Why? |
| Monocytes | 1 | 2017 | 2978 | 0.02 | Why? |
| Pandemics | 3 | 2020 | 389249 | 0.02 | Why? |
| Pneumonia, Viral | 3 | 2020 | 243684 | 0.02 | Why? |
| CD8-Positive T-Lymphocytes | 1 | 2020 | 5837 | 0.02 | Why? |
| Disease Models, Animal | 1 | 2021 | 10998 | 0.02 | Why? |
| Lung | 2 | 2020 | 31049 | 0.01 | Why? |
| Virus Internalization | 1 | 2018 | 7921 | 0.01 | Why? |
| T-Lymphocytes | 1 | 2017 | 6670 | 0.01 | Why? |
| Cohort Studies | 1 | 2021 | 36005 | 0.01 | Why? |
| Infant, Newborn | 1 | 2017 | 23105 | 0.01 | Why? |
| Virus Replication | 1 | 2017 | 14331 | 0.01 | Why? |
| Antibodies, Monoclonal, Humanized | 1 | 2017 | 9335 | 0.01 | Why? |
| Male | 3 | 2021 | 367725 | 0.01 | Why? |
| Aged | 2 | 2021 | 215776 | 0.01 | Why? |
| Adult | 2 | 2021 | 244371 | 0.01 | Why? |
| RNA, Viral | 1 | 2020 | 32276 | 0.01 | Why? |
| Middle Aged | 2 | 2021 | 270681 | 0.01 | Why? |
| Vaccination | 1 | 2017 | 19050 | 0.01 | Why? |
| Young Adult | 1 | 2020 | 93724 | 0.01 | Why? |
| Antiviral Agents | 1 | 2017 | 41703 | 0.00 | Why? |
Wrapp's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(113)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(314)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_